Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus

被引:8
|
作者
Kelepouris, Ellie [1 ]
St. Peter, Wendy [2 ,3 ]
Neumiller, Joshua J. [4 ]
Wright, Eugene E. [5 ]
机构
[1] Univ Penn, Div Renal Electrolyte & Hypertens, Philadelphia, PA 19104 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Hennepin Healthcare Res Inst, Minneapolis, MN USA
[4] Washington State Univ, Spokane, WA USA
[5] Charlotte Area Hlth Educ Ctr, Charlotte, NC USA
关键词
Chronic kidney disease; Type 2 diabetes mellitus; Multidisciplinary care; Multidisciplinary team; Care optimization; Prevention; CARDIOVASCULAR OUTCOMES; PHARMACIST INTERVENTION; MEDICATION ADHERENCE; THERAPY MANAGEMENT; NEPHROPATHY; NEPHROLOGY; MORTALITY; CKD; HOSPITALIZATION; FINERENONE;
D O I
10.1007/s13300-023-01416-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is the leading cause of chronic kidney disease (CKD), a condition associated with significant morbidity and mortality. As these patients have a high risk of developing cardiovascular disease and end-stage kidney disease, there is a need for early detection and early initiation of appropriate therapeutic interventions that slow disease progression and prevent adverse outcomes. Due to the complex nature of diabetes and CKD management, a holistic, patient-centered, collaborative care approach delivered by a coordinated multidisciplinary team (ideally including a clinical pharmacist as part of a comprehensive medication management program) is needed. In this review, we discuss the barriers to effective care, the current multidisciplinary approach used for CKD prevention and treatment, and the potential ways that the multidisciplinary management of CKD associated with type 2 diabetes mellitus can be refined to improve patient outcomes.
引用
收藏
页码:1111 / 1136
页数:26
相关论文
共 50 条
  • [21] Management of diabetes mellitus in patients with chronic kidney disease
    Allison J. Hahr
    Mark E. Molitch
    Clinical Diabetes and Endocrinology, 1 (1):
  • [22] Finerenone cardiorenal effects and its placement in treatment of chronic kidney disease in patients with type 2 diabetes mellitus: A review
    Salukhov, Vladimir V.
    Shamkhalova, Minara S.
    Duganova, Alla, V
    TERAPEVTICHESKII ARKHIV, 2023, 95 (03) : 261 - 273
  • [23] Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
    Wanner, Christoph
    Lachin, John M.
    Inzucchi, Silvio E.
    Fitchett, David
    Mattheus, Michaela
    George, Jyothis
    Woerle, Hans J.
    Broedl, Uli C.
    von Eynatten, Maximilian
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    CIRCULATION, 2018, 137 (02) : 119 - 129
  • [24] Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes
    Filippatos, Gerasimos
    Anker, Stefan D.
    Agarwal, Rajiv
    Pitt, Bertram
    Ruilope, Luis M.
    Rossing, Peter
    Kolkhof, Peter
    Schloemer, Patrick
    Tornus, Ingo
    Joseph, Amer
    Bakris, George L.
    CIRCULATION, 2021, 143 (06) : 540 - 552
  • [25] CYSTATIN C IN THE DIAGNOSIS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Yarkova, N. A.
    Borovkov, N. N.
    Zanozina, O. V.
    Nosov, V. P.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2013, 5 (04) : 89 - 92
  • [26] QUALITY OF LIFE ASPECTS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CHRONIC KIDNEY DISEASE
    Pantea Stoian, Anca Mihaela
    Stefan, Diana Simona
    Elian, Viviana
    Dobjanschi, Carmen
    INTERDISCIPLINARY APPROACHES IN DIABETIC CHRONIC KIDNEY DISEASE, 2015, : 271 - 277
  • [27] Effect of alogliptin on hypertensive chronic kidney disease patients with type 2 diabetes mellitus
    Said, Amira
    Hussain, Nadia
    Al Haddad, Amal Hussain Ibrahim
    Javid, Farideh
    AUSTRALASIAN MEDICAL JOURNAL, 2018, 11 (02): : 113 - 123
  • [28] The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening
    Otieno, Frederick C. F.
    Ogola, Elijah N.
    Kimando, M. W.
    Mutai, Kenn
    BMC NEPHROLOGY, 2020, 21 (01)
  • [29] CHRONIC KIDNEY DISEASE IN PATIENTS WITH LONG-TERM TYPE 1 DIABETES MELLITUS
    Yevloyeva, Madina I.
    Arutyunova, Margarita S.
    Severina, Anastasia S.
    Trubitsyna, Natalia P.
    Zaitseva, Natalia V.
    Shamhalova, Minara S.
    Shestakova, Marina V.
    DIABETES MELLITUS, 2023, 26 (06): : 504 - 514
  • [30] The potential role of finerenone in patients with type 1 diabetes and chronic kidney disease
    Vasco, Maria Adelaida Escobar
    Fantaye, Samuel H.
    Raghunathan, Sapna
    Solis-Herrera, Carolina
    DIABETES OBESITY & METABOLISM, 2024, 26 (10): : 4135 - 4146